CHO Plus, Inc.
Improving therapeutic protein manufacturing by genetically engineering mammalian cells that are up to 4.5-fold more productive.
- Stage Product In Development
- Industry Biotechnology
- Location San Francisco, CA, US
- Currency USD
- Founded March 2014
- Employees 3
- Incorporation Type C-corp
- Website CHO-Plus.com
Company Summary
CHO Plus has developed patented technology to genetically engineer mammalian cells for producing therapeutic proteins. Our engineered cells are capable of up to 4.5-fold more productivity than the parent cells. CHO Plus will create manufacturing cell lines for pharmaceutical companies and charge license fees plus royalties on gross product sales. An early exit is likely via acquisition by a pharma company or a CMO.
Team
-
Founder and CEO
Mr. Forman has 37 years’ experience in academic and industrial biological and biotechnology research and process development. Key areas of expertise include mammalian cell culture process development, medium development, cell banking, and GMP manufacturing of therapeutic proteins. Mr. Forman has worked at Genentech, CuraGen, and he has consulted for numerous biopharmaceutical companies.
-
Co-Founder and Chief Scientific Advisor
Dr. Chasin is a professor of Biological Sciences at Columbia University. He created two Chinese Hamster ovary cell lines currently used by most of the world's pharmaceutical companies for therapeutic protein production. Dr. Chasin's research has been aimed at discovering the sequence signals in DNA that control the expression of Human genes.
-
James PanekCOO
Mr. Panek has 40+ years of experience in the biotechnology and pharmaceutical industries, focusing on process development and manufacturing. He has held senior management positions at Genentech. VaxGen, Celltrion. He has led the development of one of world's largest biopharmaceutical manufacturing facilities.
Advisors
Previous Investors
-
Nan LiuUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.